CERo Therapeutics (CERO) via Phoenix Biotech (PBAX) deck
CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to enter clinical trials in 2024.
%20via%20Phoenix%20Biotech%20(PBAX)%20deck){kind=link}